We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Report Finds FDA Whistleblower Protection Policy Still Lacking
Report Finds FDA Whistleblower Protection Policy Still Lacking
House and Senate lawmakers are demanding the FDA strengthen its whistleblower protections after concluding the agency improperly spied on emails of five agency scientists in the CDRH device review division who reported product safety concerns to Congress.